???global.info.a_carregar???
Carina Peres is currently a Post-Doctoral research fellow at Prof. Adriana Santos' lab (3DS - Drug Discovery, Development and Safety group) at the Health Sciences Research Centre (CICS), integrated in the University of Beira Interior. Carina has a BSc and a MSc degrees in Biochemistry awarded by the Universidade da Beira Interior. She concluded her PhD degree in 2020 in Pharmacy (specialty: Pharmaceutical technology) awarded by the Faculty Pharmacy of the University of Lisbon. Carina started her research carrier in 2009, when she was awarded with an Integration into Research Grant in cancer biology field, at the Health Sciences Research Centre (CICS), integrated in the Faculty of Sciences - Universidade da Beira Interior. Carina participated in other research projects in cancer field during her Master Thesis in Biochemistry at the Universidade da Beira Interior, and then, at the University of York, during a summer research internship funded by the prestigious International Association for the Exchange of Students for Technical Experience (IASTE) scheme. Later, Carina developed her PhD studies at Prof. Helena Florindo's lab (iMed.ULisboa) in the development and assessment of a breast carcinoma vaccine based on a multifunctional engineered-nanoparticulate system able to target dendritic cells (DC), as well as to modulate immunosuppressive cytokine levels at tumor microenvironment. In 2020, she started a Post-Doctoral position of a LaCaixa-funded international consortium (CoVax, LCF/TR/CD20/52700005) on COVID nanomedicine field, involving iMedULisboa (Lisboa, Portugal), and Tel Aviv University (Tel Aviv, Israel). Carina is also participating in other 3 international research consortia, namely i) LaCaixa-funded international consortium NanoPanther (LCF/PR/HR19/52160021) on pancreatic cancer nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), Prince Felipe Research Center (CIPF) (Valencia, Spain) and Tel Aviv University (Tel Aviv, Israel), ii) FCT-funded project NanoMetBrain (PTDC/BTM-SAL/4350/2021), on melanoma-brain metastasis nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), IMM (Lisboa, Portugal) and Tel Aviv University (Tel Aviv, Israel), and iii) FCT-funded project NxGNanoTher (UTAP-EXPL/NPN/0041/2021), on breast cancer nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), IMM (Lisboa, Portugal) and University of Texas (Austin, USA), in which she has a core function. Overall, Carina interacted with more than 50 authors (+10 nationalities), publishing in total 13 articles, 4 book chapters, and 5 conference proceedings with a cumulative impact factor of 134 and a total of 446 citations. The publication list includes top specialty journals, as Nat Nanotech, Adv Drug Deliv Rev, J Control Release or Acta Biomater. Carina also presented her work at several national and international meetings (8 oral communications and 18 posters). She was supported with 4 travel grants from renowned scientific societies to participate in highly recognized international meetings, including the Federation of European Biochemical Societies (FEBS) and the Association for Cancer Immunotherapy (CIMT). Also, Carina was awarded 2 travel grants by the European Commission sponsored COST Mission (BM1402) to enroll in a training school at MRC Harwell (UK) and another at Novartis (Basel, Switzerland). She had also been part of the team of 5 FCT-funded projects, and 2 international consortiums. Carina is also involved in the lab management and is actively mentoring and/or supervising PhD and MSc students, and undergraduate students (research training within Project curricular unit at FFUL). Also, she has been involved in the organization of 5 national and 1 international scientific meetings.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Carina Sofia Gonçalves Peres

Nomes de citação

  • Peres, Carina

Identificadores de autor

Ciência ID
1211-6FBA-E335
ORCID iD
0000-0001-9399-9156
Google Scholar ID
https://scholar.google.pt/citations?user=KxsBcdIAAAAJ&hl=pt-PT&oi=ao
Scopus Author Id
56797773600

Endereços de correio eletrónico

  • cperes@fcsaude.ubi.pt (Profissional)
  • carinaperes.bq@gmail.com (Pessoal)

Moradas

  • CICS-UBI - Health Sciences Research Centre, Faculty of Health Sciences, University of Beira Interior, 6200-506, Covilhã, Covilhã, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências da Engenharia e Tecnologias - Nanotecnologia
  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia
  • Ciências Médicas e da Saúde - Medicina Básica - Imunologia
  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Médicas e da Saúde - Ciências da Saúde - Doenças Infeciosas

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Alemão Utilizador elementar (A1) Utilizador elementar (A2) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Português (Idioma materno)
Formação
Grau Classificação
2023/06/19 - 2023/07/30
Em curso
 Clinical Trials (Pós-Graduação)
Universidade de Lisboa Faculdade de Medicina, Portugal
2020/05
Concluído
 Pharmacy (Doutoramento)
Especialização em Pharmaceutical technology
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation" (TESE/DISSERTAÇÃO)
 Summa cum laude
2014/10 - 2014/10
Concluído
 Course on Laboratory Animal Science (FELASA Category B) (Diploma de especialização)
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2014/03 - 2014/03
Concluído
 Advanced Training Course on Cell Culture (Diploma de especialização)
Universidade Lusófona, Portugal
 18
2012/06
Concluído
 Biochemistry (Mestrado integrado)
Universidade da Beira Interior, Portugal
"Androgens in breast cancer cells physiology: a connection with calcium homeostasis?" (TESE/DISSERTAÇÃO)
 18
2010/06
Concluído
 Biochemistry (Licenciatura)
Universidade da Beira Interior, Portugal
 16
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/07/01 - 2023/06/30 Pós-doutorado (Investigação) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
2020/12 - 2022/06/30 Pós-doutorado (Investigação) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2015/03 - 2022/06/30 Investigador visitante (Investigação) Instituto de Medicina Molecular João Lobo Antunes, Portugal
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2013/03 - 2022/06/30 Investigador (Investigação) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2012/08 - 2012/09 Investigador (Investigação) University of York Centre for Immunology and Infection, Reino Unido
University of York Centre for Immunology and Infection, Reino Unido
2011/09 - 2012/06 Estagiário de Investigação (Investigação) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
2009/09 - 2010/08 Estagiário de Investigação (Investigação) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2013/03 - 2022/06/30 Laboratory Management Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Projetos

Bolsa

Designação Financiadores
2022/07/01 - 2023/06/30 SAIN - Segesterone Acetate Intranasal Nanoemulsion
CENTRO-45-2021-02
Investigador Pós-doutorado
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Em curso

Projeto

Designação Financiadores
2022/01/01 - Atual Multifunctional nano-immunotherapy for melanoma brain metastases treatment
PTDC/BTM-SAL/4350/2021
Investigador Pós-doutorado
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Instituto de Medicina Molecular João Lobo Antunes, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel
Fundação para a Ciência e a Tecnologia
Em curso
2022/01 - 2023/07/30 Next-generation nanomaterials to sensitize breast cancer to immunotherapy
UTAP-EXPL/NPN/0041/2021
Investigador Pós-doutorado
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Instituto de Medicina Molecular João Lobo Antunes, Portugal

The University of Texas at Austin, Estados Unidos
Em curso
2021/01 - 2022/06/30 Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines
LCF/PR/HR19/52160021
Investigador Pós-doutorado
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe, Espanha

Tel Aviv University Sackler Faculty of Medicine, Israel
“La Caixa” Banking Foundation
Em curso
2020/12 - 2022/06/30 Development of a translational COVID-19 Vaccine
_
Bolseiro de Pós-Doutoramento
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel
“La Caixa” Banking Foundation
Desativado
2019/09 - 2020/09 Modulation of melanoma-stroma interactions using a rationally designed nanomedicine combining BRAFi, MEKi and immunotherapies
ENMed/0051/2016
Bolseiro de Investigação
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel

Weizmann Institute of Science, Israel
Fundação para a Ciência e a Tecnologia
2018/07 - 2019/06 Targeting tumor microenvironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy
ENMed/0003/2015
Bolseiro de Investigação
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
2017/06 - 2018/05 Multidisciplinary Strategy to Develop Novel Multicomponent Nanoscale Systems for Immune Modulation
UTAP-ICDT/DTP-FTO/0016/2014
Bolseiro de Investigação
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
2014/04 - 2015/09 TherMelVac - Dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
PTDC/SAU-FAR/119389/2010
Investigador
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
Produções

Publicações

Artigo em conferência
  1. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogerio S; Conde, J.P.; Helena F Florindo. "PO-415 Multivalent polymeric nanoparticles as an innovative cancer immunotherapy for colorectal cancer". 2018.
    10.1136/esmoopen-2018-eacr25.926
  2. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, E; Ana I. Matos; Vicent, MJ; Helena F Florindo. "PO-416 A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma". 2018.
    10.1136/esmoopen-2018-EACR25.927
  3. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "ML-07.01.3-001: Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment". 2016.
    10.1111/febs.13805
  4. Ricardo J Marques; Vaz, CV; Peres, Carina; Gomes, I.; SANTOS, Cecilia R A; Maia, Cláudio J. B.; Socorro, Sílvia. "177 Effect of Androgens on the Expression of Ca2+-binding Protein, Regucalcin, and Ca2+-channels in MCF-7 Cells". 2012.
    10.1016/s0959-8049(12)70876-6
  5. Maia, Cláudio J. B.; Vaz, CV; Peres, Carina; SANTOS, Cecilia R A; Socorro, Sílvia. "Regucalcin, a calcium-binding protein, is a new target gene in human prostate cancer?". 2010.
Artigo em revista
  1. Matos, Ana I.; Peres, Carina; Carreira, Barbara; Moura, Liane I. F.; Acúrcio, Rita C.; Vogel, Theresa; Wegener, Erik; et al. "Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors". Advanced Science (2023): http://dx.doi.org/10.1002/advs.202300299.
    10.1002/advs.202300299
  2. Pires, David; Mandal, Manoj; Matos, Ana I.; Peres, Carina; Catalão, Maria João; Azevedo-Pereira, José Miguel; Satchi-Fainaro, Ronit; Florindo, Helena F.; Anes, Elsa. "Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis". Antibiotics 12 4 (2023): 729. http://dx.doi.org/10.3390/antibiotics12040729.
    10.3390/antibiotics12040729
  3. Carreira, Barbara; Acúrcio, Rita A.; Pozzi, Sabina; Kleiner, Ron; Moura, Liane I.; Matos, Ana I.; vaskovich, Daniela; et al. "Abstract 835: Translational nanotechnology-based cancer vaccine to re-educate host immune response against metastatic cancers". Cancer Research 83 7_Suppleme (2023): 835-835. http://dx.doi.org/10.1158/1538-7445.am2023-835.
    10.1158/1538-7445.am2023-835
  4. Peres, Carina; Ana I. Matos; Moura, Liane I F; Acúrcio, Rita C; Carreira, Bárbara; Pozzi, Sabina; Vaskovich-Koubi, Daniella; et al. "Preclinical models and technologies to advance nanovaccine development". Advanced Drug Delivery Reviews (2021):
    Publicado • 10.1016/j.addr.2021.03.001
  5. Carreira, Bárbara; Acúrcio, Rita C; Ana I. Matos; Peres, Carina; Pozzi, Sabina; Vaskovich-Koubi, Daniella; Kleiner, Ron; et al. "Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment". Advanced Therapeutics (2020): 2000147. http://dx.doi.org/10.1002/adtp.202000147.
    Publicado • 10.1002/adtp.202000147
  6. Peres, Carina; Tanaka, Yuetsu; Martin, Fabiola; Fox, James. "Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitors". Journal of Virological Methods 274 (2019): 113728. http://dx.doi.org/10.1016/j.jviromet.2019.113728.
    Publicado • 10.1016/j.jviromet.2019.113728
  7. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Ana I. Matos; Kleiner, Ron; et al. "Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators". Nature Nanotechnology 14 9 (2019): 891-901. http://dx.doi.org/10.1038/s41565-019-0512-0.
    Publicado • 10.1038/s41565-019-0512-0
  8. Ana I. Matos; Carreira, Bárbara; Peres, Carina; Moura, Liane I F; Conniot, João; Thibaut Fourniols; Anna Scomparin; et al. "Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer". Journal of Controlled Release 307 (2019): 108-138. https://doi.org/10.1016/j.jconrel.2019.06.017.
    10.1016/j.jconrel.2019.06.017
  9. Moura, Liane I F; Alessio Malfanti; Peres, Carina; Ana I. Matos; Elise Guegain; Vanessa Sainz; Mire Zloh; María J. Vicent; Helena F Florindo. "Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders". Materials Horizons 6 10 (2019): 1956-1973. https://doi.org/10.1039/C9MH00628A.
    Publicado • 10.1039/C9MH00628A
  10. Sainz, Vanessa; Moura, Liane I F; Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Wagner, Angela M.; Vela Ramirez, Julia E.; et al. "a-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma". Acta Biomaterialia 76 (2018): 193-207. http://dx.doi.org/10.1016/j.actbio.2018.06.029.
    10.1016/j.actbio.2018.06.029
  11. Silva, Ana Luísa; Peres, Carina; Conniot, João; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Sainz, Vanessa; et al. "Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation". Seminars in Immunology 34 (2017): 3-24. http://dx.doi.org/10.1016/j.smim.2017.09.003.
    10.1016/j.smim.2017.09.003
  12. Peres, Carina; Ana I. Matos; Conniot, João; Sainz, Vanessa; Zupancic, Eva; Silva, Joana M.; Graca, Luis; et al. "Poly(lactic acid)-based particulate systems are promising tools for immune modulation". Acta Biomaterialia 48 (2017): 41-57. http://dx.doi.org/10.1016/j.actbio.2016.11.012.
    10.1016/j.actbio.2016.11.012
  13. Zupancic, Eva; Peres, Carina; Ana I. Matos; Lopes, João; Moreira, João Nuno; Gaspar, Rogerio S; Helena F Florindo. "Translational Peptide-associated Nanosystems: Promising Role as Cancer Vaccines". Current Topics in Medicinal Chemistry 16 3 (2016): 291-313. http://dx.doi.org/10.2174/1568026615666150701115508.
    10.2174/1568026615666150701115508
  14. Sainz, Vanessa; Peres, Carina; Ciman, T.; Rodrigues, Catarina; Viana, Ana S. or Viana, Ana; Afonso, C. A. M.; Barata, T.; et al. "Optimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approach". RSC Advances 6 106 (2016): 104502-104512. http://dx.doi.org/10.1039/c6ra19092h.
    10.1039/C6RA19092H
  15. Sainz, Vanessa; Conniot, João; Ana I. Matos; Peres, Carina; Zupanoio, Eva; Moura, Liane I F; Silva, Liana C; Helena Florindo; Gaspar, Rogerio S. "Regulatory aspects on nanomedicines". Biochemical and Biophysical Research Communications 468 3 (2015): 504-510. http://dx.doi.org/10.1016/j.bbrc.2015.08.023.
    Publicado • 10.1016/j.bbrc.2015.08.023
  16. Ricardo J Marques; Peres, Carina; Vaz, CV; Gomes, Inês M.; Figueira, Marília I.; Cairrao, Elisa; Ignacio Verde; Maia, Cláudio J. B.; Socorro, Sílvia. "5a-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth". Medical Oncology 32 9 (2015): http://dx.doi.org/10.1007/s12032-015-0676-x.
    Publicado • 10.1007/s12032-015-0676-x
Capítulo de livro
  1. Silva, A.L.; Moura, L.I.F.; Carreira, B.; Conniot, J.; Matos, A.I.; Peres, C.; Sainz, V.; et al. "Functional Moieties for Intracellular Traffic of Nanomaterials". 399-448. 2018.
  2. Lambricht, L.; Peres, C.; Florindo, H.; Préat, V.; Vandermeulen, G.. "Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems". 185-203. 2017.
  3. Gaspar, Diana; Peres, Carina; Helena F Florindo; Almeida, António. "Mucosal Immunization Using Polyester-Based Particulate Systems". In Handbook of Polyester Drug Delivery Systems, 521-561. Singapura: Pan Stanford, 2016.
    10.1201/b20045-17
  4. Zupancic, Eva; Silva, Joana; Peres, Carina; Silva, Liana C; Gaspar, Rogerio S; Préat, Véronique; Helena F Florindo. "Immunomodulation against microbial pathogens through dendritic cells". In Microbial pathogens and strategies for combating them: science, technology and education, 1686-1705. Formatex Research Center, 2013.
    Publicado
Poster em conferência
  1. Peres, Carina. "Stable Segesterone Acetate Nanoemulsions for Neuroprotection". Trabalho apresentado em EUFEPS Annual Meeting 2023, 2023.
  2. Acúrcio, Rita C; Mendes, Nicole; Carreira, Bárbara; Ana I. Matos; Peres, Carina; Vicent, Maria; Satchi-Fainaro, Ronit; Helena F Florindo. "Unlocking Pancreatic Cancer to Nano-Immunotherapy". Trabalho apresentado em EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  3. Peres, Carina; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Graca, Luis; Satchi-Fainaro, Ronit; Helena F Florindo. "Multifunctional nanovaccine synergizes with OX40 agonist in triple-negative breast cancer". Trabalho apresentado em EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  4. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, A. S.; Graca, Luis; Satchi-Fainaro, Ronit; Helena F Florindo. "Targeted nanovaccine as a powerful platform to improve immune modulation and checkpoint therapies in colorectal cancer". Trabalho apresentado em EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  5. Moura, Liane I F; Malfanti, Alessio; Duro-Castano, A; Dordevic, S; Matos, Ana I.; Carina G. Peres; Carreira, Bárbara; et al. "Multivalent branched polypeptide-based nanovaccine as a novel immunotherapeutic approach for melanoma". Trabalho apresentado em II ASPIC-ASEICA International Meeting – Current Trends of Precision Medicine in Cancer., 2021.
  6. Peres, Carina; Ana I. Matos; Moura, Liane I F; Conniot, João; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Préat, Véronique; et al. "Multifunctional nanovaccine synergizes with immune checkpoint therapy against triple-negative breast cancer". Trabalho apresentado em EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  7. Conniot, João; Scomparin, Anna; Carreira, Bárbara; Peres, Carina; Ana I. Matos; Acúrcio, Rita C; Moura, Liane I F; et al. "Functionalized nanobiomaterials as novel combination immunotherapies in cancer". Trabalho apresentado em EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  8. Ana I. Matos; Pena, Sandra; Mateus, Mariana; Carreira, Bárbara; Peres, Carina; Moura, Liane I F; Viana, Ana S. or Viana, Ana; et al. "Targeted nanovaccine as a powerful platform to improve immune modulation therapy in colorectal cancer". Trabalho apresentado em EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  9. Peres, Carina; Tanaka, Yuetsu; Martin, Fabiola; Fox, James. "Flow cytometric methodology for the detection of de novo human T-lymphotropic virus-1 infection in vitro and as a tool to study novel infection inhibitors". Trabalho apresentado em 19th International Congress HTLV 2019, 2019.
  10. Peres, Carina; Ana I. Matos; Moura, Liane I F; Conniot, João; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; et al. "Nanoparticle-based vaccine improved the anti-tumor efficacy of the immune checkpoint co-stimulator OX40 in breast carcinoma". Trabalho apresentado em 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting, 2018.
  11. Peres, Carina; Conniot, João; Moura, Liane I F; Ana I. Matos; Scomparin, Anna; Yeini, Eilam; Graca, Luis; et al. "Polymeric Nano-vaccines Improved OX40 Anti-tumor Efficacy Against Breast Cancer". Trabalho apresentado em Controlled Release Society Annual Meeting and Exposition, 2018.
  12. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Zupancic, Eva; Jung, Steffen; Satchi-Fainaro, Ronit; Helena F Florindo. "Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma". Trabalho apresentado em Frontiers in Immunomodulation and Cancer Therapy, 2018.
  13. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma". Trabalho apresentado em Frontiers in Immunomodulation and Cancer Therapy, 2018.
  14. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma.". Trabalho apresentado em 25th Biennial Congress of the European Association for Cancer Research, 2018.
  15. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogerio S; Conde, J.P.; Helena Florindo. "Multivalent polymeric nanoparticles as an innovative cancer immunotherapy for colorectal cancer". Trabalho apresentado em EACR25: From Fundamental Insight to Rational Cancer Treatment, 2018.
  16. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based nanosystem as an anti-cancer immunotherapeutic approach for melanoma.". Trabalho apresentado em 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice, 2018.
  17. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Zupancic, Eva; Jung, Steffen; Satchi-Fainaro, Ronit; Helena F Florindo. "Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma". Trabalho apresentado em 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immunotherapy., 2018.
  18. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogério; Conde, J.P.; Helena F Florindo. "Multivalent polymeric nanoparticles for combinatorial innovative colorectal cancer immunotherapy and immunomodulation". Trabalho apresentado em 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immuntherapy, 2018.
  19. Peres, Carina; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Scomparin, Anna; Yeini, Eilam; Viana, Ana S. or Viana, Ana; et al. "Nanoparticle-based vaccine improved OX40 anti-tumor efficacy in breast cancer". Trabalho apresentado em 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immunotherapy., 2018.
  20. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogério; Conde, J.P.; Helena Florindo. "Multivalent PLGA-based nanoparticles for combinatorial innovative colorectal cancer immunotherapy and immunomodulation". Trabalho apresentado em 3rd ASPIC International Congress, 2018.
  21. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena Florindo. "Multifunctional polypeptide-based platform as an anti-cancer immunotherapeutic approach for melanoma". Trabalho apresentado em XII Spanish-Portuguese Conference on Controlled Drug Delivery, 2018.
  22. Coelho, Ainhoa; Peres, Carina; Conniot, João; Afonso, C.A.; Helena Florindo; Lopes, João. "A Quality-By-Design Approach for the Understanding of the Effect of Model of Antigen Mannose on PLGA Nanoparticles". Trabalho apresentado em XXV Encontro Nacional de Química, 2017.
  23. Peres, Carina; Moura, Liane I F; Ana I. Matos; Sainz, Vanessa; Viana, Ana S. or Viana, Ana; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticles as cancer vaccines and immunomodulators". Trabalho apresentado em 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  24. Ana I. Matos; Peres, Carina; Moreiras, Hugo; Viana, Ana S. or Viana, Ana; Graca, Luis; Barral, Duarte C.; Conde, J.P.; Helena F Florindo. "Multivalent Polymeric Nanoparticles for Colorectal Cancer Immunotherapy and Immunomodulation". Trabalho apresentado em 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  25. Sainz, Vanessa; Peres, Carina; Moura, Liane I F; Ana I. Matos; Viana, Ana S. or Viana, Ana; Lopes, João; Gaspar, Maria Manuela; et al. "Hybrid Lipid-Polymeric Nanoparticles for the Treatment of Melanoma by Strengthening the Host Immune Response". Trabalho apresentado em 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  26. Peres, Carina; Moura, Liane I F; Ana I. Matos; Sainz, Vanessa; Viana, Ana S. or Viana, Ana; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticles as breast cancer vaccines and immunomodulators". Trabalho apresentado em GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  27. Ana I. Matos; Peres, Carina; Moreiras, Hugo; Viana, Ana S. or Viana, Ana; Graca, Luis; Barral, Duarte C.; Gaspar, Rogério; Conde, J.P.; Helena F Florindo. "Multivalent polymeric based biodegradable nanoparticles for colorectal cancer immunotherapy and immunomodulation". Trabalho apresentado em GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  28. Conniot, João; Scomparin, Anna; Yeini, Eilam; Zupancic, Eva; Peres, Carina; Jung, Steffen; Helena F Florindo; Satchi-Fainaro, Ronit. "Dendritic cell-targeted nanoparticle cancer vaccine enhances immune checkpoint therapy for melanoma". Trabalho apresentado em GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  29. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Gaspar, Rogério; Vicent, María J.; Helena F Florindo. "A novel multifunctional star-shaped polypeptide-based platform as an anti-cancer immunotherapeutic approach". Trabalho apresentado em GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  30. Helena F Florindo; Zupancic, Eva; Peres, Carina; Sainz, Vanessa; Ana I. Matos; Moura, Liane I F; Curato, Caterina; et al. "Multicomponent Nanoscale Systems for Immune Modulation Against Solid Tumors.". Trabalho apresentado em Frontiers in Cancer Immunotherapy, 2017.
  31. Peres, Carina; Sainz, Vanessa; Ana I. Matos; Viana, Ana S. or Viana, Ana; Moura, Liane I F; Graca, Luis; Préat, Véronique; Helena F Florindo. "Multicomponent aliphatic polyester-based nanoparticles for antigen delivery and immune modulation against cancer disease". Trabalho apresentado em NanoBio&Med2016, 2016.
  32. Peres, Carina; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric Nanoparticle-Based Vaccine to Target Dendritic Cells and The Tumor Microenvironment". Trabalho apresentado em 8th iMed.ULisboa Postgraduate Students Meeting and 1st i3DU Meeting, 2016.
  33. Peres, Carina; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment". Trabalho apresentado em Encontro Ciência’16, 2016.
  34. Peres, Carina; Ana I. Matos; Catarina Cunha-Santos, A; Viana, Ana S. or Viana, Ana; Wagner, Angela M.; Vela Ramirez, Julia E.; Goncalves, Joao; et al. "Polymeric nanoparticle-based vaccine to target dendritic cells and the tumor microenvironment". Trabalho apresentado em UT Austin - Portugal Program Annual Conference, 2016.
  35. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine to target dendritic cells and the tumor microenvironment". Trabalho apresentado em 14th CIMT Annual Meeting – Mechanisms of efficacy in cancer immunotherapy, 2016.
  36. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine to deliver tumor-associated antigens and for immunomodulation". Trabalho apresentado em 2nd ASPIC International Congress, 2016.
  37. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine: targeting dendritic cells and the tumor microenvironment". Trabalho apresentado em XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”, 2016.
  38. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoplatform to deliver tumor-associated antigens and for immunomodulation". Trabalho apresentado em 7th iMed.ULisboa Postgraduate Students Meeting, Faculty of Pharmacy of the University of Lisbon, 2015.
  39. Ana I. Matos; Peres, Carina; Ventura, Ana Ester; Viana, Ana S. or Viana, Ana; Borrego, Pedro; Gois, Pedro; Silva, Liana C; Taveira, Nuno; Helena F Florindo. "Development of PLGA-based nanocarriers for Human Immunodeficiency Virus Type 1 vaccine delivery.". Trabalho apresentado em Molecular and Supramolecular Carriers for Imaging and Therapy Conference, FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks", 2015.
  40. Peres, Carina; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based cancer vaccine to deliver tumor associated antigens and for immunomodulation". Trabalho apresentado em GRC Cancer Nanotechnology – Nanomedicines from Laboratory to Clinical Reality, 2015.
  41. Peres, Carina; Silva, Joana M.; Graca, Luis; Gaspar, Rogério; Préat, Véronique; Helena F Florindo. "Multifunctional aliphatic polyester-based biodegradable nanoparticles for vaccine delivery and immunomodulation". Trabalho apresentado em Cancer Nanotechnology – Nanomedicines from Laboratory to Clinical Reality, 2015.
  42. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Nanoparticle-based cancer vaccine to deliver tumor associated antigens and for immunomodulation". Trabalho apresentado em 1st ASPIC International Congress, 2014.
  43. Silva, Joana M.; Zupancic, Eva; Peres, Carina; Sainz, Vanessa; Videira, Mafalda; Graca, Luis; Moreira, João Nuno; Préat, Véronique; Helena F Florindo. "Development of multifunctional aliphatic polyester-based biodegradable nanoparticles for vaccine delivery and immunotherapy". Trabalho apresentado em Showcasing Portuguese Pharma Science: Advances in Discovery, Development and Manufacturing, 2014.
  44. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation". Trabalho apresentado em 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2014.
  45. Marques, Ricardo; Vaz, CV; Peres, Carina; Gomes, Inês; SANTOS, Cecilia R A; Maia, Cláudio J. B.; Socorro, Sílvia. "Effect of androgens on the expression of Ca2+-binding protein, regucalcin, and Ca2+-channels in MCF-7 cells". Trabalho apresentado em 22nd Congress of European Association for Cancer Research - from Basic Research to Personalized Cancer Treatment, 2012.
  46. Maia, Cláudio J. B.; Vaz, CV; Peres, Carina; SANTOS, Cecilia R A; Socorro, Sílvia. "Regucalcin, a calcium-binding protein, is a new target gene in human prostate cancer?". Trabalho apresentado em The 16th International Charles Heidelberger Symposium on Cancer Research, 2010.
Pré-impressão
  1. Kumar, Saumya; Basto, Afonso P.; Ribeiro, Filipa; Almeida, Silvia C. P.; Campos, Patricia; Peres, Carina; Al-Khalidi, Sarwah; et al. "Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue". 2022. http://dx.doi.org/10.1101/2022.07.28.501817.
    10.1101/2022.07.28.501817
Tese / Dissertação
  1. Peres, Carina. "Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation". Doutoramento, Universidade de Lisboa Instituto de Investigação do Medicamento, 2020.
  2. Peres, Carina. "Androgens in breast cancer cells physiology: a connection with calcium homeostasis?". Mestrado, Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, 2012.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2023/05/31 Intranasal Segesterone Acetate Nanoemulsion Development – safety evaluation EUFEPS Annual Meeting 2023
EUFEPS (Lisbon, Portugal)
2023/03/20 Nose-to-brain delivery. PhD and Postgraduate Advanced Course – Advanced Drug Delivery
Faculty of Pharmacy, Universidade de Lisboa (Lisbon, Portugal)
2023/03/20 Development of Micro and Nanoemulsions for Intranasal Delivery of the neuroprotectant Nestorone to the brain 4th European Conference on Pharmaceutics
(Marseille, França)
2023/02/14 Development of safe micro and nanoemulsions for nose-to-brain delivery of the neuroprotectant Nestorone HSR Congress 2023
CICS - Centro de Investigação em Ciências da Saúde (Covilhã, Portugal)
2023/02/06 Desenvolvimento de uma nanovacina para o tratamento do cancro de mama CICS-UBI Fora de Portas – O Cancro Trocado por Miúdos
CICS - Centro de Investigação em Ciências da Saúde (Covilhã, Portugal)
2021/01/21 Multivalent branched polypeptide-based nanovaccine as promising immunotherapeutic strategy for melanoma. 3rd SPLC-CRS Young Scientists Virtual Meeting
SPLC-CRS
2020/09/23 Nanotechnological approaches for immune modulation against solid cancers. NanoPT 2020
2020/06/29 Nanovaccines as modulators of germinal center responses against cancer CRS Virtual Meeting 2020
CRS
2019/10/09 Multifunctional nanovaccine synergizes with immune checkpoint therapy against triple negative breast cancer Immunology Club Seminar
Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal)
2019/09/12 Multi-targeting nano-based platform as an effective immunotherapy against solid tumors Nanotechnology in Cancer: Engineering for Oncology
(Cambridge, Reino Unido)
2019/07/21 Dendritic Cell-targeted Nano-vaccines Synergize With Myeloid-Derived Suppressor Cells Inhibitor And Immune Checkpoints Modulators For Melanoma Therapy Controlled Release Society Annual Meeting & Exposition
CRS (Barcelona, Espanha)
2019/06/23 Nano-Vaccine Delivery Overcomes Resistance to Immune Checkpoint Therapy GRC Cancer Nanotechnology - Bridging the Translational Gap in Cancer Nanotechnology
Gordon Research Conferences (Mount Snow, West Dover (VT), Estados Unidos)
2018/11/20 Polymeric nano-vaccines improved immune checkpoint anti-tumor efficacy against breast cancer NanoBio&Med2018
(Barcelona, Espanha)
2018/07/22 Dendritic Cell-targeted Nano-vaccines Synergize With Immune Checkpoint Modulators For Melanoma Treatment Controlled Release Society Annual Meeting and Exposition
Controlled Release Society (New York, Estados Unidos)
2018/05/28 A Novel Multifunctional Polypeptide-Based Nanosystem As An Anti-Cancer Immunotherapeutic Approach For Melanoma 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice
(Valencia, Espanha)
2018/05/28 A Novel Multifunctional Polypeptide-Based Nanosystem As An Anti-Cancer Immunotherapeutic Approach For Melanoma. 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice
(Valencia, Espanha)
2018/01/14 Combination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma XII Spanish-Portuguese Conference on Controlled Drug Delivery
Spanish-Portuguese Conference on Controlled Drug Delivery (Coimbra, Portugal)
2017/11/22 Combination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma NanoBio&Med2017
(Barcelona, Espanha)
2017/07/13 Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma 9th iMed.ULisboa and 2nd I3DU Postgraduate Students Meeting
(Lisbon, Portugal)
2017/04/23 A novel nanoplatform as metastatic melanoma cancer vaccine 1st SPLC-CRS Young Scientist Meeting
Spanish-Portuguese Conference on Controlled Drug Delivery (Santiago de Compostela, Espanha)
2016/09/03 Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment 41st Federation of European Biochemical Societies (FEBS) congress
Federation of European Biochemical Societies (Ephesus/Kusadasi, Turquia)
2016/08/31 Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment 16th FEBS Young Scientists’ Forum
Federation of European Biochemical Societies (Ephesus/Kusadasi, Turquia)
2016/01/21 Melanoma cancer vaccine based on multifunctional nanoparticles for antigen delivery and immunomodulation. XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”
Spanish-Portuguese Conference on Controlled Drug Delivery (Granada, Espanha)
2016/01/21 Development of polymeric vaccine delivery nanosystems for HIV/AIDS control through dendritic cell modulation XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”
Spanish-Portuguese Conference on Controlled Drug Delivery (Granada, Espanha)
2015/11/26 Androgens as calcium-modulators in human breast cancer cells: effect of the 5a-dihydrotestosterone in MCF-7 cells I Congress in Health Sciences Research: Towards Innovation and Entrepreneurship Trends in Endocrinology and Neurosciences
(Covilhã, Portugal)
2015/07/13 Multicomponent nanoparticles for vaccine delivery and immunomodulation Molecular and Supramolecular Carriers for Imaging and Therapy Conference, FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks"
FP7-PEOPLE-2012-ITN - Marie-Curie Action (Lisbon, Portugal)
2014/10/10 Multivalent nanoparticle-based cancer vaccine to deliver tumor-associated antigens and for immunomodulation Workshop Nano2014
(Lisbon, Portugal)
2014/07/02 PLA-based nanoparticles as a cancer vaccine to deliver tumor-associated antigens and for immunomodulation 6th iMed.ULisboa Postgraduate Students Meeting
(Lisbon, Portugal)
2013/12/18 Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation Nanomedicines classes of the 5th year of the Integrated Master in Pharmaceutical Sciences
Universidade de Lisboa, Faculty of Pharmacy (Lisbon, Portugal)
2012/07/03 Androgens in breast cancer cells physiology - a connection with calcium homeostasis? VI Symposium of the Health Sciences Research Centre
(Covilhã, Portugal)
2012/07/03 Regucalcin regulation by extracellular calcium in prostate cells. VI Symposium of the Health Sciences Research Centre
(Covilhã, Portugal)

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2021/09/01 - 2021/12/31 Modulation of melanoma tumor microenvironment
Coorientador
 Ciências Farmacêuticas (Iniciação científica)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/03/01 - 2021/09/30 Dendritic cell regulation by a novel mannosylated nanovaccine
Coorientador
 Ciências Farmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/03/01 - 2021/06/30 Development of nanoparticle-based immunotherapy using chitosan as an immunomodulator
Coorientador
 Biologia Celular e Molecular (Licenciatura/Bacharelato)
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2020/09 - 2020/12 Production of a novel mannosylated nanovaccine
Coorientador
 Ciências Farmacêuticas (Iniciação científica)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2017/09 - 2018/02 Polymeric nanoparticle-based vaccine: the impact of surfactants and mannose functionalization on in vitro uptake by APC
Coorientador
 Ciências Farmacêuticas (Iniciação científica)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2014/09 - 2015/02 Vaccination with PLGA nanoparticles: formulation and quantification of the residual surfactant
Coorientador
 Mestrado integrado em Ciências Farmacêuticas (Iniciação científica)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2014/09/01 - 2014/09/28 European Researcher's Night, National Museum of Natural History and Science, Lisbon, Portugal (2014/09/27 - 2014/09/27)
2014/07/01 - 2014/07/05 6th iMed.ULisboa Postgraduate Students Meeting, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (2014/07/03)
Encontro (Membro da Comissão Organizadora)
 Universidade de Lisboa Faculdade de Farmácia, Portugal
2014/03/25 - 2014/04/04 9th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Centro de Congressos de Lisboa, Lisbon, Portugal (2014/03/31 - 2014/04/03)
Congresso (Coorganizador)
2013/09/01 - 2013/09/28 European Researcher's Night, National Museum of Natural History and Science, Lisbon, Portugal (2013/09/27 - 2013/09/27)
2013/07/01 - 2013/07/19 5th iMed.UL Postgraduate Students Meeting, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (2013/07/18)
Encontro (Membro da Comissão Organizadora)
 Universidade de Lisboa Faculdade de Farmácia, Portugal
2009/11/01 - 2009/11/30 4th National Meeting of Biochemistry Students (ENEBIOQ), Universidade da Beira Interior, Covilhã, Portugal (2009/11/26 - 2009/11/29)
Encontro (Coorganizador)
 Universidade da Beira Interior, Portugal

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2021/02/23 Nanoplatform to modulate dendritic cells and tumor microenvironment against triple negative breast cancer
Arguente
 Mafalda Carvalho Verdial (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2021/01 - Atual Drug Delivery and Translational Research Springer

Membro de associação

Nome da associação Tipo de participação
2016/02 - Atual Spanish-Portuguese Local Chapter of the Controlled Release Society (SPLC-CRS)
2015/06 - Atual Association for Cancer Immunotherapy (CIMT)
2015/03 - Atual Portuguese Association for Cancer Research (ASPIC)
2015/03 - Atual European Association for Cancer Research (EACR)
2013/04 - 2017/03 Portuguese Biochemical Society (SPB)

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2013/01 - 2014/12 iMed.ULisboa postgraduate Students Commission (ipSC) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Distinções

Prémio

2022 Bursary to attend the 2022 IUBMB-FEBS-PABMB YSF and FEBS Congresses
Federation of European Biochemical Societies, Reino Unido
2018 Travel Award to attend the 16th CIMT Annual Meeting¿- Pushing Frontiers in Cancer Immunotherapy
2018 Best Poster Award at the 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2017 Bursary to attend the training school entitled "Drug Discovery and Development" at Novartis (Basel, Switzerland)
2016 Travel Award to attend the 14th CIMT Annual Meeting - Mechanisms of Efficacy in Cancer Immunotherapy
2016 Bursary to attend the 16th FEBS Young Scientists Forum/ 41st Federation of European Biochemical Societies (FEBS) congress, Kusadasi, Turkey
2015 Young Scientist Award for the best oral presentation at the Molecular and Supramolecular Carriers for Imaging and Therapy Conference
2015 Bursary to attend the training school entitled "Creating and Phenotyping Mouse models of Disease and Ageing", at MRC Harwell Institute (United Kingdom)
2012 Short Oral Communication Award at the VII Annual CICS Symposium
Universidade da Beira Interior, Portugal
2012 PhD fellowship (SFRH/BD/87591/2012)
Fundação para a Ciência e a Tecnologia, Portugal
2010 Merit Scholarship
Universidade da Beira Interior, Portugal

Ministério da Educação, Portugal